< Articles
5 Steps To Avoid Patentability Issues in Clinical Trials
Posted on
18 May, 2021
By
IPOS International
By
IPOS International
In pharmaceutical drug development, clinical trial details made publicly available may jeopardise the patentability of the drug. Yet, supporting data such as trial results are needed for a successful patent application!
How then, can biotechnology companies resolve this conundrum? Our '5 Steps To Avoid Patentability Issues in Clinical Trials' infographic provides some tips.
For a deeper dive, watch a presentation by our patent examiner Dr Angelina Lim on this conundrum:
As the expertise arm of IPOS, IPOS International helps enterprises and industries use IP and intangible assets for business growth. To learn how you can leverage on your IP, email us at [email protected].
Book a complimentary chat with us to learn how you can leverage on your IP.
Book IA Chat Session
